SCITECH

SciTech is a clinical stage, biopharmaceutical company that has developed a proprietary nano-delivery system (SciTech Drug Delivery Platform - SDP) to enable intravenous (IV) delivery of water-insoluble drugs. One such challenged drug or active pharmaceutical ingredient (API) is fenretinide, the API in SciTech's lead drug candidate, has been shown in numerous clinical trials to be a relatively safe and effective anticancer therapy with targeted cancer destroying activity. The patented combination of the new SDP and fenretinide has led to SciTech's first drug candidate, ST-001 nanoFenretinide, that holds the promise of improving and saving many lives... SciTech is a clinical stage, specialty pharmaceutical company that has developed a proprietary nanoparticle delivery platform (SciTech Drug Delivery Platform, SDP) to maximize the bioavailability of water-insoluble therapeutics, while maintaining or improving safety profiles... SciTech is seeking funding and strategic partnerships to..

Also known as: SciTech Development, SciTech Development LLC

Primary location: Grosse Pointe Farms United States